Ameritas Investment Partners’s Quest Diagnostics DGX Stock Holding History

Ameritas Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.9M	Sell	8,951 -21	-0.2%	-$4.12K	0.05%	400
2026 Q1	$1.76M	Sell	8,972 -146	-2%	-$28.4K	0.05%	383
2025 Q4	$1.58M	Sell	9,118 -580	-6%	-$106K	0.05%	413
2025 Q3	$1.85M	Sell	9,698 -436	-4%	-$77.4K	0.06%	365
2025 Q2	$1.82M	Sell	10,134 -371	-4%	-$64.4K	0.06%	375
2025 Q1	$1.78M	Buy	10,505 +310	+3%	+$50.9K	0.06%	378
2024 Q4	$1.54M	Sell	10,195 -14	-0.1%	-$2.18K	0.05%	457
2024 Q3	$1.58M	Buy	10,209 +1,440	+16%	+$215K	0.05%	447
2024 Q2	$1.2M	Buy	8,769 +7,520	+602%	+$1.03M	0.04%	543
2024 Q1	$166K	Hold	1,249	–	–	0.01%	1421
2023 Q4	$172K	Sell	1,249 -126	-9%	-$16.6K	0.01%	1368
2023 Q3	$168K	Hold	1,375	–	–	0.01%	1300
2023 Q2	$193K	Hold	1,375	–	–	0.01%	1150
2023 Q1	$195K	Hold	1,375	–	–	0.01%	1118
2022 Q4	$202K	Sell	1,375 -143	-9%	-$20.5K	0.01%	1133
2022 Q3	$186K	Hold	1,518	–	–	0.01%	1096
2022 Q2	$201K	Hold	1,518	–	–	0.01%	1065
2022 Q1	$208K	Sell	1,518 -127	-8%	-$17.7K	0.01%	1162
2021 Q4	$285K	Hold	1,645	–	–	0.01%	1022
2021 Q3	$239K	Sell	1,645 -202	-11%	-$29.6K	0.01%	1081
2021 Q2	$244K	Hold	1,847	–	–	0.01%	1098
2021 Q1	$237K	Sell	1,847 -213	-10%	-$26.2K	0.01%	1101
2020 Q4	$245K	Sell	2,060 -93	-4%	-$11.3K	0.01%	1027
2020 Q3	$246K	Hold	2,153	–	–	0.01%	931
2020 Q2	$245K	Sell	2,153 -115	-5%	-$12.2K	0.01%	923
2020 Q1	$182K	Hold	2,268	–	–	0.01%	978
2019 Q4	$242K	Hold	2,268	–	–	0.01%	978
2019 Q3	$243K	Sell	2,268 -144	-6%	-$14.8K	0.01%	957
2019 Q2	$246K	Hold	2,412	–	–	0.01%	962
2019 Q1	$217K	Hold	2,412	–	–	0.01%	999
2018 Q4	$201K	Sell	2,412 -170	-7%	-$15.9K	0.01%	960
2018 Q3	$279K	Hold	2,582	–	–	0.01%	909
2018 Q2	$284K	Sell	2,582 -237	-8%	-$24.7K	0.01%	888
2018 Q1	$283K	Sell	2,819 -192	-6%	-$19.7K	0.01%	918
2017 Q4	$297K	Sell	3,011 -152	-5%	-$14.4K	0.01%	889
2017 Q3	$342K	Hold	3,163	–	–	0.02%	841
2017 Q2	$352K	Hold	3,163	–	–	0.02%	835
2017 Q1	$311K	Sell	3,163 -160	-5%	-$15.3K	0.02%	870
2016 Q4	$305K	Hold	3,323	–	–	0.02%	865
2016 Q3	$281K	Sell	3,323 -22,442	-87%	-$1.88M	0.02%	880
2016 Q2	$2.1M	Sell	25,765 -15,735	-38%	-$1.2M	0.14%	160
2016 Q1	$2.96M	Buy	41,500 +10,000	+32%	+$671K	0.2%	103
2015 Q4	$2.24M	Hold	31,500	–	–	0.15%	150
2015 Q3	$1.94M	Hold	31,500	–	–	0.14%	171
2015 Q2	$2.28M	Sell	31,500 -2,665	-8%	-$197K	0.15%	155
2015 Q1	$2.63M	Buy	34,165 +17,865	+110%	+$1.28M	0.17%	132
2014 Q4	$1.09M	Buy	16,300 +7,800	+92%	+$492K	0.07%	264
2014 Q3	$515K	Hold	8,500	–	–	0.04%	550
2014 Q2	$498K	Hold	8,500	–	–	0.04%	593
2014 Q1	$492K	Buy	+8,500	New	+$456K	0.04%	576

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ameritas Investment Partners's DGX Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Quest Diagnostics (DGX) stake by 0.23% in Q2 2026, selling an estimated $4.12K and leaving 8,951 shares worth $1.9M. The position accounts for 0.05% of the portfolio, ranked #400.

Ameritas Investment Partners first reported a position in DGX in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.96M in Q1 2016. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Ameritas Investment Partners held 8,951 shares of Quest Diagnostics worth $1.9M as of Q2 2026.
Ameritas Investment Partners sold 21 Quest Diagnostics shares in Q2 2026, an estimated $4.12K.
Quest Diagnostics made up 0.05% of Ameritas Investment Partners's portfolio in Q2 2026, its #400 holding.
Ameritas Investment Partners first reported a position in Quest Diagnostics in Q1 2014 and has held it in 50 quarters since.
Ameritas Investment Partners's Quest Diagnostics position peaked at $2.96M in Q1 2016.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.